Approved November 1996
seasonal allergic rhinitis
Astelin nasal spray has been approved for the treatment of symptoms associated with seasonal allergic rhinitis.
It offers a valuable treatment option for the estimated 20-40 million Americans who suffer from seasonal allergic rhinitis, the fifth most common chronic illness that causes millions of lost work days and significant discomfort for the sufferer.
The Astelin nasal spray drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.